4
MARKET OVERVIEW
Rising demand for rapid diagnostics driven by aging population and infectious disease prevalence.
52
4.2.1.1
INCREASING NUMBER OF SEPSIS PATIENTS AND RISING COST OF TREATMENT
4.2.1.2
RAPID GROWTH IN GERIATRIC POPULATION WITH CHRONIC DISEASES
4.2.1.3
HIGH INCIDENCE OF BLOODSTREAM INFECTIONS
4.2.1.4
GROWING DEMAND FOR RAPID DIAGNOSTIC TECHNIQUES
4.2.1.5
HIGH PREVALENCE OF INFECTIOUS DISEASES
4.2.2.1
HIGH COST OF AUTOMATED BLOOD CULTURE INSTRUMENTS
4.2.2.2
LACK OF TRAINED LABORATORY TECHNICIANS
4.2.3.1
GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
4.2.3.2
INCREASED NEED TO IDENTIFY ANTIBIOTIC-RESISTANT MICROORGANISMS
4.2.4.1
LONG TURNAROUND TIME ASSOCIATED WITH CONVENTIONAL BLOOD CULTURE WORKFLOWS
4.2.4.2
BLOOD CULTURE CONTAMINATION AND PRE-ANALYTICAL ERRORS
4.3
UNMET NEEDS & WHITE SPACES
4.3.1
UNMET NEEDS IN BLOOD CULTURE TESTS MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1
KEY MOVES & STRATEGIC FOCUS
5
INDUSTRY TRENDS
Analyze strategic forces shaping the blood culture tests market and investment opportunities.
63
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
BARGAINING POWER OF SUPPLIERS
5.1.2
BARGAINING POWER OF BUYERS
5.1.3
THREAT OF NEW ENTRANTS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS & FORECAST
5.3
SUPPLY CHAIN ANALYSIS
5.5.1
BLOOD CULTURE TESTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS,
AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS,
5.7.1
IMPORT SCENARIO (HS CODE 382100)
5.7.2
EXPORT SCENARIO (HS CODE 382100)
5.8
KEY CONFERENCES & EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10
INVESTMENT & FUNDING SCENARIO
5.11.1
ENHANCED STAINING AND WORKFLOW PROTOCOLS IMPROVE DETECTION OF FASTIDIOUS ORGANISMS IN POSITIVE BLOOD CULTURES
5.11.2
RAPID BLOOD CULTURE IDENTIFICATION AND ANTIMICROBIAL STEWARDSHIP REDUCE TIME TO OPTIMAL THERAPY
5.12
IMPACT OF 2025 US TARIFFS ON BLOOD CULTURE TESTS MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.5
IMPACT ON END-USE INDUSTRIES
5.12.5.1
HOSPITAL LABORATORIES
5.12.5.2
REFERENCE LABORATORIES
5.12.5.3
ACADEMIC RESEARCH LABORATORIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations redefine blood culture tests, unlocking rapid diagnostics and transformative market potential.
81
6.1.1
CULTURE-BASED TECHNOLOGIES
6.1.2
MOLECULAR TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.4.1
LIST OF MAJOR PATENTS
6.6
IMPACT OF AI/GENERATIVE AI ON BLOOD CULTURE TESTS MARKET
6.6.2
TOP USE CASES & MARKET POTENTIAL
6.6.3
KEY COMPANIES IMPLEMENTING AI
7
SUSTAINABILITY & REGULATORY LANDSCAPE
Navigate complex eco-regulations and sustainability initiatives shaping the global blood culture test market.
88
7.1
REGIONAL REGULATIONS & COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
ENVIRONMENTAL IMPACT & ECO-FRIENDLY INITIATIVES IN BLOOD CULTURE TESTS
7.2.1.1
ECO-FRIENDLY INITIATIVES
7.3
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock hidden revenue by addressing unmet needs and overcoming adoption barriers in buyer decision-making.
93
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS ACROSS VARIOUS END USERS
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9
BLOOD CULTURE TESTS MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 99 Data Tables
99
9.2.1
BLOOD CULTURE MEDIA
9.2.1.1
AEROBIC BLOOD CULTURE MEDIA
9.2.1.1.1
GROWING BLOOD CULTURE VOLUMES TO SUPPORT AEROBIC MEDIA MARKET GROWTH
9.2.1.2
PEDIATRIC AEROBIC BLOOD CULTURE MEDIA
9.2.1.2.1
RISING PEDIATRIC SEPSIS BURDEN TO DRIVE DEMAND FOR SPECIALIZED LOW-VOLUME BLOOD CULTURE BOTTLES
9.2.1.3
ANAEROBIC BLOOD CULTURE MEDIA
9.2.1.3.1
INCREASED NEED FOR ROUTINE DIAGNOSIS OF BACTERIA IN BLOOD CULTURE TO DRIVE SEGMENT
9.2.1.4
MYCOBACTERIAL BLOOD CULTURE MEDIA
9.2.1.4.1
PERSISTENT GLOBAL TB BURDEN TO DRIVE DEMAND FOR MYCOBACTERIAL BLOOD CULTURE MEDIA
9.2.1.5
FUNGI/YEAST BLOOD CULTURE MEDIA
9.2.1.5.1
EASY IDENTIFICATION AND CHARACTERIZATION OF SPECIAL FUNGAL SPECIES TO DRIVE SEGMENT
9.2.2
ASSAY KITS & REAGENTS
9.2.2.1
INCREASED NEED FOR RAPID IDENTIFICATION OF BACTERIA AND YEAST FROM POSITIVE BLOOD CULTURES TO DRIVE MARKET
9.2.3
BLOOD CULTURE ACCESSORIES
9.2.3.1
GROWING NUMBER OF BLOOD CULTURE TESTS TO DRIVE MARKET
9.3.1
AUTOMATED BLOOD CULTURE SYSTEMS
9.3.1.1
NEED FOR AUTOMATED IMAGING SYSTEMS AND ADVANCED ALGORITHMS TO DRIVE MARKET
9.3.2
SUPPORTING LABORATORY EQUIPMENT
9.3.2.1.1
INCUBATORS TO PROVIDE OPTIMAL ENVIRONMENT WITH ADEQUATE TEMPERATURE AND OXYGEN LEVELS FOR MICROBIAL GROWTH
9.3.2.2.1
COLONY COUNTERS TO INCREASE DIRECT IMAGE SCANNING AND ANALYSIS CAPABILITY
9.3.2.3.1
GROWING EMPHASIS ON RAPID PRELIMINARY IDENTIFICATION TO FUEL DEMAND FOR MICROSCOPES
9.3.2.4.1
GRAM STRAINERS TO GUIDE INITIAL ANTIBIOTIC SECTION AND APPROPRIATE EMPIRICAL THERAPY
9.3.2.5
OTHER SUPPORTING EQUIPMENT
9.4.1
INCREASED NEED FOR AUTOMATED SYSTEMS IN HOSPITAL-BASED LABORATORIES TO DRIVE MARKET
10
BLOOD CULTURE TESTS MARKET, BY METHOD
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 13 Data Tables
144
10.2
CONVENTIONAL/MANUAL BLOOD CULTURES
10.2.1
LOWER CAPITAL REQUIREMENTS TO DRIVE ADOPTION OF CONVENTIONAL BLOOD CULTURE METHODS IN RESOURCE-CONSTRAINED SETTINGS
10.3
AUTOMATED BLOOD CULTURES
10.3.1
NEED FOR FASTER TURNAROUND TIMES TO FUEL TRANSITION TOWARD AUTOMATED BLOOD CULTURE METHODS
11
BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 33 Data Tables
152
11.2
CULTURE-BASED TECHNOLOGIES
11.2.1
ADVANCEMENTS IN AUTOMATED DETECTION TO STRENGTHEN CULTURE-BASED TECHNOLOGIES SEGMENT
11.3
MOLECULAR TECHNOLOGIES
11.3.1.1
REDUCED RISK OF CONTAMINATION AND EASY DETECTION OF BLOODSTREAM INFECTIONS TO DRIVE SEGMENT
11.3.2.1
DETERMINATION OF BETTER GENOTYPING CHARACTERIZATION AND IDENTIFICATION OF BACTERIAL INFECTIONS TO DRIVE SEGMENT
11.3.3.1
RAPID SPECIES-LEVEL IDENTIFICATION TO STRENGTHEN ROLE OF PNA-FISH IN BLOODSTREAM INFECTION DIAGNOSIS
12
BLOOD CULTURE TESTS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 16 Data Tables
168
12.2.1
GROWING INCIDENCE OF SEPSIS CASES GLOBALLY TO DRIVE MARKET
12.3.1
INCREASING INCIDENCE OF BLOODSTREAM INFECTIONS TO DRIVE MARKET
12.4
MYCOBACTERIAL DETECTION
12.4.1
HIGH GLOBAL TB BURDEN AND CONCENTRATION OF CASES IN HIGH-RISK POPULATIONS TO DRIVE DEMAND
13
BLOOD CULTURE TESTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 21 Data Tables
177
13.2
HOSPITAL LABORATORIES
13.2.1
INCREASED ABILITY TO CONDUCT LARGE VOLUME OF BLOOD CULTURE TESTS TO DRIVE MARKET
13.3
REFERENCE LABORATORIES
13.3.1
GROWING REFERRAL AND SPECIALIZED TESTING NEEDS TO FUEL REFERENCE LABORATORY DEMAND
13.4
ACADEMIC RESEARCH LABORATORIES
13.4.1
GROWING FOCUS ON NOVEL DIAGNOSTIC DEVELOPMENT TO FUEL BLOOD CULTURE TESTING IN RESEARCH LABORATORIES
14
BLOOD CULTURE TESTS MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 12 Countries | 211 Data Tables.
188
14.2.1
NORTH AMERICA: MACROECONOMIC OUTLOOK
14.2.2.1
RISING SEPSIS BURDEN AND ANTIMICROBIAL RESISTANCE TO DRIVE DEMAND FOR BLOOD CULTURE TESTING IN US
14.2.3.1
INCREASING MRSA BLOODSTREAM INFECTION BURDEN TO STRENGTHEN DEMAND
14.3
BLOOD CULTURE TESTS MARKET: VOLUME ANALYSIS
14.3.2
NORTH AMERICA: BLOOD CULTURE SETS VOLUME
14.4.1
EUROPE: MACROECONOMIC OUTLOOK
14.4.2.1
EXPANDING HEALTHCARE INVESTMENT AND INPATIENT CARE SPENDING TO DRIVE ADOPTION
14.4.3.1
RISING AMR-RELATED BACTEREMIA AND E. COLI PREVALENCE TO EXPAND BLOOD CULTURE TESTING
14.4.4.1
RISING HEALTHCARE EXPENDITURE AND HIGH PHYSICIAN DENSITY TO STRENGTHEN ADOPTION
14.4.5.1
EXPANDING MICROBIOLOGY SURVEILLANCE AND CONTINUED HEALTHCARE INVESTMENT TO SUPPORT ITALY’S MARKET
14.4.6.1
GROWING ELDERLY POPULATION AND HEALTHCARE UTILIZATION TO SUSTAIN DEMAND
14.5.1
ASIA PACIFIC: MACROECONOMIC OUTLOOK
14.5.2.1
EXPANDING HEALTHCARE INVESTMENT AND HOSPITAL CAPACITY TO DRIVE BLOOD CULTURE TESTING DEMAND IN CHINA
14.5.3.1
EXTENSIVE HOSPITAL INFRASTRUCTURE TO SUSTAIN DEMAND
14.5.4.1
RISING GOVERNMENT HEALTHCARE EXPENDITURE TO SUPPORT EXPANSION OF DIAGNOSTIC AND LABORATORY INFRASTRUCTURE
14.5.5
REST OF ASIA PACIFIC
14.6.1
LATIN AMERICA: MACROECONOMIC OUTLOOK
14.6.2.1
GROWTH IN HOSPITAL-SERVICE EXPENDITURE TO SUPPORT MODERNIZATION OF BRAZIL'S CLINICAL DIAGNOSTIC INFRASTRUCTURE
14.6.3.1
STRENGTHENING AMR LABORATORY REQUIREMENTS TO SUPPORT ADOPTION
14.6.4
REST OF LATIN AMERICA
14.7
MIDDLE EAST & AFRICA
14.7.1
MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
15
COMPETITIVE LANDSCAPE
Uncover key player strategies driving dominance in the blood culture tests market landscape.
283
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1
OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BLOOD CULTURE TESTS MARKET
15.3
REVENUE ANALYSIS, 2023–2025
15.4
MARKET SHARE ANALYSIS, 2025
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.5.5.1
COMPANY FOOTPRINT
15.5.5.2
REGION FOOTPRINT
15.5.5.3
OFFERING FOOTPRINT
15.5.5.4
METHOD FOOTPRINT
15.5.5.5
TECHNOLOGY FOOTPRINT
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.1
PROGRESSIVE COMPANIES
15.6.2
RESPONSIVE COMPANIES
15.6.5
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
15.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
15.6.5.3
COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
15.7
COMPANY VALUATION & FINANCIAL METRICS
15.8
BRAND/PRODUCT COMPARISON
15.9
COMPETITIVE SCENARIO
15.9.1
PRODUCT LAUNCHES & APPROVALS
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
299
16.1.1
WATERS CORPORATION
16.1.1.1
BUSINESS OVERVIEW
16.1.1.2
PRODUCTS OFFERED
16.1.1.3
RECENT DEVELOPMENTS
16.1.1.3.1
PRODUCT APPROVALS
16.1.1.4.2
STRATEGIC CHOICES
16.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
16.1.3
THERMO FISHER SCIENTIFIC, INC.
16.1.4
DANAHER CORPORATION
16.1.5
F. HOFFMANN-LA ROCHE LTD.
16.1.7
BRUKER CORPORATION
16.1.8
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
16.1.9
AUTOBIO DIAGNOSTICS CO., LTD.
16.1.10
SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.
16.2.1
HIMEDIA LABORATORIES PVT. LTD.
16.2.3
LABOTRONICS SCIENTIFIC
16.2.6
ZHUHAI DEER BIOENGINEERING CO., LTD.
16.2.7
ZHUHAI MEIHUA MEDICAL TECHNOLOGY CO. LTD.
16.2.8
FISON INSTRUMENTS LTD.
16.2.10
LABTRON EQUIPMENT LTD.
16.2.12
COPAN ITALIA S.P.A.
16.2.13
GREINER BIO-ONE INTERNATIONAL GMBH
16.2.14
LIOFILCHEM S.R.L.
16.2.15
TITAN BIOTECH LTD.
17
RESEARCH METHODOLOGY
350
17.2.1
SECONDARY RESEARCH
17.2.1.1
KEY DATA FROM SECONDARY SOURCES
17.2.2.1
KEY DATA FROM PRIMARY SOURCES
17.2.2.2
KEY INDUSTRY INSIGHTS
17.3
MARKET SIZE ESTIMATION
17.3.1
BOTTOM-UP APPROACH
17.3.1.1
APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
17.3.1.2
APPROACH 2: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
17.4
MARKET BREAKDOWN & DATA TRIANGULATION
17.5
MARKET SHARE ANALYSIS
17.6
RESEARCH ASSUMPTIONS
17.6.1
GROWTH RATE ASSUMPTIONS
17.7
RESEARCH LIMITATIONS
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3
CUSTOMIZATION OPTIONS
TABLE 1
ESTIMATED NUMBER OF PEOPLE LIVING WITH HIV, ALL AGES, 2010, 2023, AND 2024 (MILLION PEOPLE)
TABLE 2
TOTAL TUBERCULOSIS INCIDENCE, BY REGION, 2024
TABLE 3
BLOOD CULTURE TESTS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4
GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 5
AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 6
AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 7
IMPORT DATA FOR HS CODE 382100-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 8
EXPORT DATA FOR HS CODE 382100-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 9
BLOOD CULTURE TESTS MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 10
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 11
LIST OF MAJOR PATENTS PERTAINING TO BLOOD CULTURE TESTS MARKET, 2023–2025
TABLE 12
KEY COMPANIES IMPLEMENTING AI IN BLOOD CULTURE TESTS MARKET
TABLE 13
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
GLOBAL STANDARDS IN BLOOD CULTURE TESTS MARKET
TABLE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
TABLE 20
KEY BUYING CRITERIA, BY OFFERING
TABLE 21
ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 22
BLOOD CULTURE TESTS MARKET: UNMET NEEDS ACROSS VARIOUS END USERS
TABLE 23
BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 24
BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 25
BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 26
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 27
EUROPE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 28
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 29
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 30
EXAMPLES OF BLOOD CULTURE MEDIA
TABLE 31
BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 32
BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 33
NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34
EUROPE: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35
ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36
LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37
AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 38
NORTH AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39
EUROPE: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40
ASIA PACIFIC: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41
LATIN AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 43
NORTH AMERICA: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44
EUROPE: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45
ASIA PACIFIC: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46
LATIN AMERICA: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47
ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48
NORTH AMERICA: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49
EUROPE: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50
ASIA PACIFIC: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51
LATIN AMERICA: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52
MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 53
NORTH AMERICA: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54
EUROPE: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
ASIA PACIFIC: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56
LATIN AMERICA: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57
FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 58
NORTH AMERICA: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59
EUROPE: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60
ASIA PACIFIC: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61
LATIN AMERICA: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62
EXAMPLES OF BLOOD CULTURE ASSAY KITS & REAGENTS
TABLE 63
BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 64
NORTH AMERICA: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65
EUROPE: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66
ASIA PACIFIC: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67
LATIN AMERICA: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68
EXAMPLES OF BLOOD CULTURE ACCESSORIES
TABLE 69
BLOOD CULTURE ACCESSORIES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 70
NORTH AMERICA: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71
EUROPE: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72
ASIA PACIFIC: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73
LATIN AMERICA: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74
BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 75
BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 76
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77
EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80
EXAMPLES OF AUTOMATED BLOOD CULTURE SYSTEMS
TABLE 81
AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 82
NORTH AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83
EUROPE: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84
ASIA PACIFIC: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85
LATIN AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86
SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 87
SUPPORTING LABORATORY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 88
NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89
EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90
ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91
LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92
INCUBATORS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 93
NORTH AMERICA: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 94
EUROPE: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95
ASIA PACIFIC: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96
LATIN AMERICA: INCUBATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97
COLONY COUNTERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 98
NORTH AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99
EUROPE: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100
ASIA PACIFIC: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 101
LATIN AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 102
MICROSCOPES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 103
NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104
EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105
ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 106
LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107
GRAM STAINERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 108
NORTH AMERICA: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 109
EUROPE: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110
ASIA PACIFIC: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111
LATIN AMERICA: GRAM STAINERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112
OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 113
NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 114
EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115
ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 116
LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 117
BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 118
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119
EUROPE: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 122
BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 123
EXAMPLES OF CONVENTIONAL/MANUAL BLOOD CULTURE PRODUCTS
TABLE 124
CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 125
NORTH AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126
EUROPE: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127
ASIA PACIFIC: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 128
LATIN AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129
EXAMPLES OF AUTOMATED BLOOD CULTURE PRODUCTS
TABLE 130
AUTOMATED BLOOD CULTURES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 131
NORTH AMERICA: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 132
EUROPE: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 133
ASIA PACIFIC: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134
LATIN AMERICA: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135
BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 136
BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 137
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 138
EUROPE: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 140
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 141
BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142
BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 143
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144
EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 146
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147
BLOOD CULTURE TESTS MARKET FOR PCR, BY REGION, 2024–2031 (USD MILLION)
TABLE 148
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149
EUROPE: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 151
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152
BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 153
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 154
EUROPE: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157
BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY REGION, 2024–2031 (USD MILLION)
TABLE 158
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 159
EUROPE: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 161
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162
EXAMPLES OF MALDI-TOF MS SYSTEMS
TABLE 163
BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 164
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165
EUROPE: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 166
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 167
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 168
BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 169
BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 170
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171
EUROPE: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 174
BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 175
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176
EUROPE: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 178
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 179
BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY REGION, 2024–2031 (USD MILLION)
TABLE 180
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181
EUROPE: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 182
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 184
BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185
BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 186
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187
EUROPE: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 189
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 190
BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 191
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 192
EUROPE: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 195
BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 196
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 197
EUROPE: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 198
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200
BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 201
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 202
EUROPE: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 203
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 204
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 205
NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 206
NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207
NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 208
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209
NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211
NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212
NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 213
NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 214
NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215
NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 216
NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 217
NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 218
US: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 219
US: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220
US: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221
US: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222
US: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 223
US: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 224
US: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 225
US: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226
US: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 227
US: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 228
CANADA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 229
CANADA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 230
CANADA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231
CANADA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232
CANADA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233
CANADA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 234
CANADA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 235
CANADA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 236
CANADA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 237
CANADA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 238
NORTH AMERICA: BLOOD CULTURE SETS VOLUME, 2024–2031 (MN UNITS)
TABLE 239
EUROPE: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 240
EUROPE: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 241
EUROPE: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 242
EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 243
EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 244
EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 245
EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 246
EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 247
EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 248
EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 249
EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 250
EUROPE: MACROECONOMIC INDICATORS
TABLE 251
GERMANY: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 252
GERMANY: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 253
GERMANY: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 254
GERMANY: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255
GERMANY: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256
GERMANY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 257
GERMANY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 258
GERMANY: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 259
GERMANY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 260
GERMANY: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 261
UK: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 262
UK: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263
UK: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 264
UK: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 265
UK: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266
UK: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 267
UK: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 268
UK: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 269
UK: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 270
UK: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 271
FRANCE: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 272
FRANCE: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 273
FRANCE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 274
FRANCE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 275
FRANCE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 276
FRANCE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 277
FRANCE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 278
FRANCE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 279
FRANCE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 280
FRANCE: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 281
ITALY: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 282
ITALY: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283
ITALY: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 284
ITALY: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285
ITALY: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286
ITALY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 287
ITALY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 288
ITALY: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 289
ITALY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 290
ITALY: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 291
SPAIN: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 292
SPAIN: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293
SPAIN: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294
SPAIN: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 295
SPAIN: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296
SPAIN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 297
SPAIN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 298
SPAIN: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 299
SPAIN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 300
SPAIN: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 301
REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 302
REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 303
REST OF EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 304
REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305
REST OF EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 306
REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 307
REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 308
REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 309
REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 310
REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 311
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 312
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 313
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 314
ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 316
ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 317
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 318
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 319
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 320
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 321
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 322
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 323
CHINA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 324
CHINA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 325
CHINA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 326
CHINA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 327
CHINA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 328
CHINA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 329
CHINA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 330
CHINA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 331
CHINA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 332
CHINA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 333
JAPAN: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 334
JAPAN: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 335
JAPAN: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 336
JAPAN: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 337
JAPAN: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 338
JAPAN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 339
JAPAN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 340
JAPAN: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 341
JAPAN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 342
JAPAN: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 343
INDIA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 344
INDIA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 345
INDIA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 346
INDIA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 347
INDIA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 348
INDIA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 349
INDIA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 350
INDIA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 351
INDIA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 352
INDIA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 353
REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 354
REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 355
REST OF ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 356
REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 357
REST OF ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 358
REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 359
REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 360
REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 361
REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 362
REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 363
LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 364
LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 365
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 366
LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 367
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 368
LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 369
LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 370
LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 371
LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 372
LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 373
LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 374
LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 375
BRAZIL: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 376
BRAZIL: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 377
BRAZIL: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 378
BRAZIL: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 379
BRAZIL: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 380
BRAZIL: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 381
BRAZIL: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 382
BRAZIL: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 383
BRAZIL: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 384
BRAZIL: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 385
MEXICO: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 386
MEXICO: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 387
MEXICO: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 388
MEXICO: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 389
MEXICO: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 390
MEXICO: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 391
MEXICO: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 392
MEXICO: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 393
MEXICO: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 394
MEXICO: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 395
REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 396
REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 397
REST OF LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 398
REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 399
REST OF LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 400
REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 401
REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 402
REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 403
REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 404
REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 405
MIIDLE EAST & AFERICA: MACROECONOMIC INDICATORS
TABLE 406
MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 407
MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 408
MIDDLE EAST & AFRICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 409
MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 410
MIDDLE EAST & AFRICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 411
MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
TABLE 412
MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 413
MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 414
MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 415
MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 416
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BLOOD CULTURE TESTS MARKET, JANUARY 2023−AUGUST 2026
TABLE 417
BLOOD CULTURE TESTS MARKET: DEGREE OF COMPETITION
TABLE 418
BLOOD CULTURE TESTS MARKET: REGION FOOTPRINT
TABLE 419
BLOOD CULTURE TESTS MARKET: OFFERING FOOTPRINT
TABLE 420
BLOOD CULTURE TESTS MARKET: METHOD FOOTPRINT
TABLE 421
BLOOD CULTURE TESTS MARKET: TECHNOLOGY FOOTPRINT
TABLE 422
BLOOD CULTURE TESTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 423
BLOOD CULTURE TESTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
TABLE 424
BLOOD CULTURE TESTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
TABLE 425
BLOOD CULTURE TESTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–AUGUST 2026
TABLE 426
BLOOD CULTURE TESTS MARKET: DEALS, JANUARY 2023–AUGUST 2026
TABLE 427
WATERS CORPORATION: COMPANY OVERVIEW
TABLE 428
WATERS CORPORATION: PRODUCTS OFFERED
TABLE 429
WATERS CORPORATION: PRODUCT APPROVALS, JANUARY 2023–JUNE 2026
TABLE 430
WATERS CORPORATION: DEALS, JANUARY 2023–JUNE 2026
TABLE 431
BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 432
BIOMÉRIEUX: PRODUCTS OFFERED
TABLE 433
BIOMÉRIEUX: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026
TABLE 434
THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
TABLE 435
THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED
TABLE 436
THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2023–JUNE 2026
TABLE 437
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 438
DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 439
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 440
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 441
F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026
TABLE 442
DIASORIN S.P.A.: COMPANY OVERVIEW
TABLE 443
DIASORIN S.P.A.: PRODUCTS OFFERED
TABLE 444
DIASORIN S.P.A.: PRODUCT APPROVALS, JANUARY 2023–JUNE 2026
TABLE 445
BRUKER CORPORATION: COMPANY OVERVIEW
TABLE 446
BRUKER CORPORATION: PRODUCTS OFFERED
TABLE 447
BRUKER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 448
BRUKER CORPORATION: DEALS, JANUARY 2023–JUNE 2026
TABLE 449
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
TABLE 450
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
TABLE 451
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026
TABLE 452
AUTOBIO DIAGNOSTICS CO., LTD.: COMPANY OVERVIEW
TABLE 453
AUTOBIO DIAGNOSTICS CO., LTD.: PRODUCTS OFFERED
TABLE 454
AUTOBIO DIAGNOSTICS CO., LTD.: DEALS, JANUARY 2023–JUNE 2026
TABLE 455
SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 456
SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
TABLE 457
HIMEDIA LABORATORIES PVT. LTD.: COMPANY OVERVIEW
TABLE 458
BIOBASE GROUP: COMPANY OVERVIEW
TABLE 459
LABOTRONICS SCIENTIFIC: COMPANY OVERVIEW
TABLE 460
HARDY DIAGNOSTICS: COMPANY OVERVIEW
TABLE 461
BIOLOG, INC.: COMPANY OVERVIEW
TABLE 462
ZHUHAI DEER BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
TABLE 463
ZHUHAI MEIHUA MEDICAL TECHNOLOGY CO. LTD.: COMPANY OVERVIEW
TABLE 464
FISON INSTRUMENTS LTD.: COMPANY OVERVIEW
TABLE 465
BINDER GMBH: COMPANY OVERVIEW
TABLE 466
LABTRON EQUIPMENT LTD.: COMPANY OVERVIEW
TABLE 467
LABNICS LTD.: COMPANY OVERVIEW
TABLE 468
COPAN ITALIA S.P.A.: COMPANY OVERVIEW
TABLE 469
GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW
TABLE 470
LIOFILCHEM S.R.L.: COMPANY OVERVIEW
TABLE 471
TITAN BIOTECH LTD.: COMPANY OVERVIEW
TABLE 472
BLOOD CULTURE TESTS MARKET: RISK ASSESSMENT
FIGURE 1
BLOOD CULTURE TESTS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3
GLOBAL BLOOD CULTURE TESTS MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2023–2025
FIGURE 5
DISRUPTIVE TRENDS IMPACTING GROWTH OF BLOOD CULTURE TESTS MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN BLOOD CULTURE TESTS MARKET, 2026–2031
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8
RISING BURDEN OF BLOODSTREAM INFECTIONS AND ANTIMICROBIAL RESISTANCE TO DRIVE MARKET GROWTH
FIGURE 9
CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 10
AUTOMATED BLOOD CULTURES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11
CULTURE-BASED TECHNOLOGIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12
BACTEREMIA SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 13
HOSPITAL-LABORATORIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 14
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 15
BLOOD CULTURE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16
BLOOD CULTURE TESTS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 17
BLOOD CULTURE TESTS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 18
BLOOD CULTURE TESTS MARKET: VALUE CHAIN ANALYSIS
FIGURE 19
BLOOD CULTURE TESTS MARKET: ECOSYSTEM ANALYSIS
FIGURE 20
BLOOD CULTURE TESTS MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 21
NUMBER OF DEALS & FUNDING ACTIVITIES IN BLOOD CULTURE TESTS MARKET
FIGURE 22
PATENT ANALYSIS FOR BLOOD CULTURE TESTS, JANUARY 2015–DECEMBER 2025
FIGURE 23
MARKET POTENTIAL OF AI IN BLOOD CULTURE TESTS MARKET
FIGURE 24
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 25
KEY BUYING CRITERIA, BY OFFERING
FIGURE 26
NORTH AMERICA: BLOOD CULTURE TESTS MARKET SNAPSHOT
FIGURE 27
ASIA PACIFIC: BLOOD CULTURE TESTS MARKET SNAPSHOT
FIGURE 28
REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2023–2025 (USD MILLION)
FIGURE 29
MARKET SHARE ANALYSIS OF KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2025
FIGURE 30
BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31
BLOOD CULTURE TESTS MARKET: COMPANY FOOTPRINT
FIGURE 32
BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33
EV/EBITDA OF KEY VENDORS
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 35
BLOOD CULTURE TESTS MARKET: BRAND/PRODUCT COMPARISON FOR AUTOMATED BLOOD CULTURE SYSTEMS
FIGURE 36
WATERS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 37
BIOMÉRIEUX: COMPANY SNAPSHOT (2025)
FIGURE 38
THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2025)
FIGURE 39
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 40
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 41
DIASORIN S.P.A.: COMPANY SNAPSHOT (2025)
FIGURE 42
BRUKER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 43
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 44
AUTOBIO DIAGNOSTICS CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 45
BLOOD CULTURE TESTS MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 46
PRIMARY SOURCES
FIGURE 47
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 48
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 49
GLOBAL BLOOD CULTURE TESTS MARKET: REVENUE SHARE ANALYSIS
FIGURE 50
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 51
TOP-DOWN APPROACH
FIGURE 52
DATA TRIANGULATION METHODOLOGY
FIGURE 53
PARAMETRIC ASSUMPTIONS
Growth opportunities and latent adjacency in Blood Culture Tests Market